MEDI4212
MEDI4212 is a humanized IgG1λ monoclonal antibody inhibitor targeting IgE. MEDI4212 potently inhibits human IgE-mediated functional responses through its receptor FcεRI, such as calcium signaling, β-hexosaminidase release and phagocytosis. MEDI4212 prevents the binding of IgE to CD23 with an IC50 of 8 nM. MEDI4212 can be used severe asthma research[1].
Product Specifications
UNSPSC
12352100
Target
Fc Receptor (FcR)
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
References & Citations
[1]Cohen ES, et al. A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma. MAbs. 2014 May-Jun;6 (3) :756-64.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
209172 25 µg
Resistin-Like beta, Recombinant, Human (RELM-beta, FIZZ2) discontinued. see R1587-20A
Sign In for Pricing
View Details 
A05690-2-APC 100 µg/Vial
Anti-SHANK1 Antibody Picoband® APC Conjugated
Sign In for Pricing
View Details